Targeting the hotspots: Investigating spatial and demographic variations in HIV infection in small communities in South Africa

Journal of the International AIDS Society

Volumn 13, Issue 1, 2010, Pages

  Wand, Handan ^a   Ramjee, Gita ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DEMOGRAPHY; FEMALE; GENITAL HERPES; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RURAL POPULATION; SCREENING TEST; SEXUAL BEHAVIOR; SOUTH AFRICA; URBAN POPULATION; ADOLESCENT; MALE; PSYCHOLOGICAL ASPECT; SEXUALITY;

ADOLESCENT; ADULT; FEMALE; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; RURAL POPULATION; SEXUAL PARTNERS; SOUTH AFRICA; YOUNG ADULT;

EID: 77958489731     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-13-41     Document Type: Article

References (21)

1. UNAIDS, 2008 Report on the global AIDS epidemic 2008 http://www.unaids. org/en/KnowledgeCentre/HIVData/GlobalReport/2008 Accessed 18 November 2008
2. O Shisana T Rehle LC Simbayi K Zuma S Jooste V Pillay-Van-Wyk N Mbelle J Van Zyl W Parker NP Zungu S Pezi the SABSSM III Implementation Team, South African national HIV prevalence, incidence, behaviour and communication survey 2008: A turning tide among teenagers? Pretoria: HSRC Press 2009
3. Geographic Distribution of Human Immunodeficiency Virus in South Africa. I Kleinschmidt A Pettifor N Morris C MacPhail H Rees, American Journal of Tropical Medicine Hygiene 2007 77 6 1163
4. Microbicides and other tropical strategies to prevent vaginal transmission oh HIV. MM Lederman RE Offord O Hartley, Nature Reviews Immunology 2006 6 371 382 10.1038/nri1848 16639430
5. Microbicides Development Programme: Design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention. A Nunn S McCormack A Crook R Pool C Rutterford R Hayes, Trials 2009 10 99 10.1186/1745-6215-10-99 19860888
6. Safety and effectiveness of vaginal microbicides BufferGel and 0.5% PRO 2000 gel for the prevention of HIV infection in Women: Results of the HPTN 035 trial (Abstract). S Abdool Karim A Coletti B Richardson G Ramjee I Hoffman M Chirenje T Taha M Kapina L Maslankowski L Soto-Torres, 16th Conference on Retroviruses and Opportunistic Infections Montreal, Canada 2009
7. K Alcorn, Disappointment as microbicide fails to protect against HIV 2009 http://www.aidsmap.com/en/news/4E30C4F2-F073-46BC-BD10-31388001230F.asp NAM, AIDS map
8. Geographic inequalities in HIV infection and AIDS in sub-Saharan Africa. JM Amar-Roze, Soc Sci Med 1999 36 10 1247 1256 10.1016/0277-9536(93)90214-O
9. Epidemiologic distribution of HIV-2 human immunodeficiency virus infection in sub-Saharan Africa. G Remy, Med Trop (Mars.) 1993 53 511 516 8139440
10. Localized spatial clustering of HIV infections in a widely disseminated rural South African epidemic. F Tanser T Barnighausen GS Cooke M-L Newell, International Journal of Epidemiology 2009 38 4 1008 1016 10.1093/ije/dyp148 19261659
11. A simulation study of three methods for detecting disease clusters. G Aamodt SO Samuelsen A Skrondal, International Journal of Health Geographics 2006 5 15 10.1186/1476-072X-5-15 16608532
12. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. NS Padian A van der Straten G Ramjee T Chipato G de Bruyn K Blanchard S Shiboski ET Montgomery H Fancher H Cheng M Rosenblum M van der Laan N Jewell J McIntyre MIRA Team, Lancet 2007 370 251 261 10.1016/S0140-6736(07)60950-7 17631387
13. HSV2 Prevalence Amongst Women Participating in HIV Prevention Studies in rural communities in Durban, South Africa - Urgent need for Microbicide Product to be Active Against HSV2 [Abstract AB14]. S Gappoo S Naidoo G Ramjee V Guddera E Raju, Microbicides 2006 Conference Durban, South Africa
14. The value of site preparedness studies for future implementation of phase 2/IIb/III HIV prevention trials: experience from the HPTN 055 study. G Ramjee S Kapiga S Weiss L Peterson C Leburg C Kelly B Masse HPTN 055 Study Team, J Acquir Immune Defic Syndr 2008 47 93 100 10.1097/QAI.0b013e31815c71f7 17984760
15. Cancer map patterns: are they random or not? M Kulldorf C Song D Gregoria H Samociuk L DeChello, Am J Prev Med 2006 30 37 s49 10.1016/j.amepre.2005.09. 009 16458789
16. M Kulldorf, SaTScan 7.0: Software for the spatial and space-time scan statistics: Information Management Services Inc 2006
17. Geographical distribution of sporatic Creutzfeldt-Jacob Disease in France. M Kulldorf, International Journal of Epidemiology 2002 31 495 496 10.1093/ije/31.2.495 11980825
18. Benchmark Data and Power Calculations for Evaluating Disease Outbreak Detection Methods. M Kulldorf Z Zhang J Hartman R Heffernan L Huang F Mostashari, MMWR 2004 53 144 151 15714644
19. Power evaluation of disease clustering tests. C Song M Kulldorf, International Journal of Health Geographics 2003 2 9 10.1186/1476-072X-2-9 14687424
20. Tuberculosis incidence in Portugal: spatiotemporal clustering. C Nunes, International Journal of Health Geographics 2007 6 30 10.1186/1476-072X-6-30 17625009
21. Spatial clustering and epidemiological aspects of visceral Leishmaniasis in two endemic villages, Baringo District, Kenya. JR Ryan J Mbui JR Rashid MK Wasunna G Kirigi C Magiri D Kinoti PM Ngumbi SK Martin SO Odera LP Hochberg CT Bautista AS Chan, American Journal of Tropical Medicine and Hygiene 2006 74 2 308 317 16474089